Clinical Trials Logo

Filter by:
NCT ID: NCT02885129 Completed - Chronic Diseases Clinical Trials

Development of the General Scale Observance for Chronic Diseases

EGOMAC
Start date: June 2014
Phase: N/A
Study type: Observational

The main objective is to assess the measurement characteristics (validity, reproducibility) and the invariance of EGOMAC scale in a population of consultants in diabetology, cardiology and rheumatology hospital and liberal and hospital oncology and Infectious disease, by following the evolution of patient compliance at D0 and D15. The second objective is to assess the sensitivity to change of scale EGOMAC following developments compliance 3 months.

NCT ID: NCT02885090 Completed - Rett Syndrome Clinical Trials

New Genes Involved in Molecular Etiology of Rett Syndrome Through DNA Microarray Comparative Genomic Hybridization

RETT
Start date: February 2010
Phase: N/A
Study type: Interventional

Rett syndrome (RTT) is a genetic encephalopathy and the typical form is caused by mutations in the gene MECP2. It is a genetically heterogeneous pathology. CDKL5 and FOXG1 have been recently discovered being involved in other forms of RTT. However, at least 5% of typical forms and more other atypical forms are not linked to any of 3 genes known to be involved in the disease. The purpose of this study is to identify new genes involved in molecular etiology of typical and atypical forms of RTT.

NCT ID: NCT02884999 Completed - Bleeding Clinical Trials

Management of Bleeding and Coagulopathy in Trauma and Compliance to European Trauma Guidelines

APP
Start date: May 2015
Phase: N/A
Study type: Observational

This cohort study describes the epidemiology of trauma patients and their management in a French academic trauma center. It also aims to determine what recommendations from the European trauma guidelines is applied in routine.

NCT ID: NCT02884804 Completed - Clinical trials for Postpartum Hemorrhage

Study of Biological Determinants of Bleeding Postpartum

HPP-IPF
Start date: November 2011
Phase: N/A
Study type: Observational

At the entry of the delivery room, a standard blood analysis will be performed (Blood count, PT, aPTT, Fibrinogen, and D-Dimer) for each women (if they are agree), according to the center's practices. The percentage of the immature platelets is a an additional parameter on the hemogram. The clinical assessments (recorded in medical records) and biological values will be used to determine if there is a correlation between these data and the occurrence of postpartum hemorrhage.

NCT ID: NCT02884752 Completed - Clinical trials for Campylobacter Infections

Retrospective Study of Bone Infection Due to Campylobacter Spp

CAMPYLO
Start date: December 2014
Phase: N/A
Study type: Observational

Only 24 cases of Campylobacter bone and joint infection (BJI) have been reported worldwide between 1955 and 2008. Between 2010 and 2012, 7 cases were observed in two University hospitals in France. This increasing number of cases raises several issues. Are they the consequences of better detections and reporting, or are they reflecting any epidemiologic changes? For answering these questions, we performed a 10 year (2002-2012) retrospective multicenter (6 centers) study on BJI (native and implanted joints) due to Campylobacter species.

NCT ID: NCT02884661 Completed - Atrial Fibrillation Clinical Trials

First-line Treatment for Atrial Fibrillation in Cardiology and Geriatric Departments

ACFA
Start date: October 2015
Phase: N/A
Study type: Observational

In order to evaluate the implementation for the recommendations about the patient care for atrial fibrillation in aged patients, a non-interventional study is performed retrospectively by comparing two approach of the focus in Cardiology Department and in Geriatric unit.

NCT ID: NCT02884622 Completed - Cystic Fibrosis Clinical Trials

DNA Methylation and Lung Disease in Cystic Fibrosis

METHYLCF
Start date: June 2013
Phase: N/A
Study type: Interventional

Lung disease progression is variable among cystic fibrosis (CF) patients and depends on DNA mutations in the CFTR gene, polymorphic variations in disease-modifier genes and environmental exposure. The contribution of genetic factors has been extensively investigated, whereas the mechanism whereby environmental factors modulate the lung disease is unknown. Because these factors can affect the epigenome, investigators hypothesized that DNA methylation variations at disease-modifier genes modulate the lung function in CF patients.

NCT ID: NCT02884609 Completed - Pain Clinical Trials

Tolerance and Efficiency of Paracetamol Subcutaneous Injection

TEPASC
Start date: August 2014
Phase:
Study type: Observational

The purpose of this study is to evaluate the tolerance and the efficiency of subcutaneous administration of Paracetamol for patients in palliative care.

NCT ID: NCT02884570 Completed - Clinical trials for Depression of Parents

Parental Mental Health After Tracheostomy in Early Childhood

TRACH
Start date: April 2014
Phase:
Study type: Observational

To assess the prevalence of anxiety / depression in post- hospital for parents (mothers and fathers) of children with tracheotomy before the age of 1 year between 2000 and 2012.

NCT ID: NCT02884557 Completed - Clinical trials for Inflammatory Bowel Diseases

NKT Role in the Regulation of the Inflammatory Bowel Disease

NKT-CSP/MICI
Start date: May 2013
Phase: N/A
Study type: Interventional

Inflammatory bowel diseases (IBD) include Crohn's disease (CD) and ulcerative colitis (UC). These diseases are a public health problem because they concern many patients (1 case in 1000). IBDs are characterized by dysregulated immune response against luminal antigens causing chronic inflammation of the gut in genetically predisposed individuals. Their exact cause is unknown and there is currently no cure. The primary sclerosing cholangitis (PSC) is a liver inflammatory disease of unknown origin that is known to be strongly associated with IBD. An important clinical observation highlights the mild symptoms of IBD when associated to the PSC. Conversely, treating PSC by liver transplant or immunosuppressive drugs is associated with a progression of intestinal inflammation. Based, on these clinical findings that suggest a protective effect regulator of liver inflammation on intestinal inflammation, and on the results obtained by our group in mouse models that identified the natural killer T cell (NKT) as essential in control of experimental colitis, the project aims to determine, using PCR, if the expression of NKT cell markers are increased in the colon of patients with PSC+IBD compared to patients with IBD alone or PSC alone.